Pfizer launches study of omicron-specific COVID-19 vaccine
Published
Pfizer and BioNTech are launching a clinical trial to test an omicron-specific version of their COVID-19 vaccine, the companies announced today. They’re moving forward with studies of a new form...
#pfizer #biontech #hospitalization